Carbogen for Apnea Testing During the Brain Death Declaration Process in Subjects on Extracorporeal Membrane Oxygenation

References

1. 1.↵
   1. Sauer CM,
   2. Yuh DD,
   3. Bonde P

   . Extracorporeal membrane oxygenation use has increased by 433% in adults in the United States from 2006 to 2011. ASAIO J 2015;61(1):31–36.

   OpenUrlPubMed
2. 2.↵
   1. Mccarthy FH,
   2. Mcdermott KM,
   3. Kini V,
   4. Gutsche J,
   5. Wald J,
   6. Xie D,
   7. et al

   . Trends in U.S. extracorporeal membrane oxygenation use and outcomes: 2002-2012. Semin Thorac Cardiovasc Surg 2015;27(2):81–88.

   OpenUrl
3. 3.↵
   1. Mateen F,
   2. Muralidharan R,
   3. Shinohara R,
   4. Paris J,
   5. Schears G,
   6. Wijdicks E

   . Neurological injury in adults treated with extracorporeal membrane oxygenation. Arch Neurol, 2011;68(12):1543–1549.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Mehta A,
   2. Ibsen LM

   . Neurologic complications and neurodevelopmental outcome with extracorporeal life support. World J Crit Care Med 2013;2(4):40–47.

   OpenUrl
5. 5.↵
   1. Nasr DM,
   2. Rabinstein AA

   . Neurologic complications of extracorporeal membrane oxygenation. J Clin Neurol 2015;11(4):383–389.

   OpenUrl
6. 6.↵
   1. Ko WJ,
   2. Lin CY,
   3. Chen RJ,
   4. Wang SS,
   5. Lin FY,
   6. Chen YS

   . Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg 2002;73(2):538–545.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Lan C,
   2. Tsai PR,
   3. Chen YS,
   4. Ko WJ

   . Prognostic factors for adult patients receiving extracorporeal membrane oxygenation as mechanical circulatory support a 14 year experience at a medical center. Artif Organs 2010;4(2):E59–E64.

   OpenUrl
8. 8.
   1. Massetti M,
   2. Tasle M,
   3. Le Page O,
   4. Deredec R,
   5. Babatasi G,
   6. Buklas D,
   7. et al

   . Back from irreversibility: extracorporeal life support for prolonged cardiac arrest. Ann Thorac Surg, 2005;79(1):178–183.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Thiagarajan RR,
   2. Brogan TV,
   3. Scheurer MA,
   4. Laussen PC,
   5. Rycus PT,
   6. Bratton SL

   . Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in adults. Ann Thorac Surg 2009;87(3):778–785.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    The Quality Standards Subcommittee of the American Academy of Neurology. Practice parameters for determining brain death in adults. Neurology 1995;45(5):1012–1014.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Wijdicks EF

    . The case against confirmatory tests for determining brain death in adults. Neurology 2010;75(1):77–83.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Wijdicks EF

    . Determining brain death in adults. Neurology 1995;45(5):1003–1011.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Ropper AH,
    2. Kennedy SK,
    3. Russell L

    . Apnea testing in the diagnosis of brain death. Clinical and physiological observations. J Neurosurg 1981;55(6):942–946.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.
    1. Muralidharan R1,
    2. Mateen FJ,
    3. Shinohara RT,
    4. Schears GJ,
    5. Wijdicks EF

    . The challenges with brain death determination in adult patients on extracorporeal membrane oxygenation. Neurocrit Care 2011;14(3):423–426.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Saposnik G,
    2. Rizzo G,
    3. Vega A,
    4. Sabbatiello R,
    5. Deluca JL

    . Problems associated with the apnea test in the diagnosis of brain death. Neurol India 2004;52(3):342–345.

    OpenUrlPubMedWeb of Science
16. 16.↵
    1. Goudreau JL,
    2. Wijdicks EF,
    3. Emery SF

    . Complications during apnea testing in the determination of brain death: predisposing factors. Neurology 2000;55(7):1045–1048.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Sharpe MD,
    2. Young GB,
    3. Harris C

    . The apnea test for brain death determination: an alternative approach. Neurocrit Care 2004;1(3):363–366.

    OpenUrlPubMed
18. 18.↵
    1. Bruce EN,
    2. Cherniack NS

    . Central chemoreceptors. J Appl Physiol 1987;62(2):389–402.

    OpenUrlPubMedWeb of Science
19. 19.↵
    1. Couture M,
    2. Pylant RT,
    3. Fancella CA

    . An alternative apnea test to determine brain death: capnography with carbogen administration (abstract). Respir Care 2007;52(11):1567.

    OpenUrl
20. 20.
    1. Madden M,
    2. Andrews P,
    3. Cho S,
    4. Habashi N

    . Successful apnea testing during veno-venous extracorporeal membrane oxygenation (VV-ECMO) (abstract). Neurocrit Care 2012;17(Suppl 2).
21. 21.↵
    1. Andrews P,
    2. Dolly K,
    3. Madden M,
    4. Habashi N

    . The use of carbogen facilitates apnea testing in a patient on venous-arterial extracorporeal membrane oxygenation (VA-ECMO) (abstract). Neurocrit Care 2012;17(Suppl 2).
22. 22.↵
    1. Jeret JS,
    2. Benjamin JL

    . Risk of hypotension during apnea testing. Arch Neurol 1994;51(6):595–599.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Wu WL,
    2. Fang Q,
    3. Li L,
    4. Qiu YQ,
    5. Luo BY

    . Complications associated with the apnea test in the determination of the brain death. Chin Med J 2008;121(13):1169–1172.

    OpenUrlPubMed
24. 24.↵
    1. Paries M,
    2. Boccheciampe N,
    3. Raux M,
    4. Riou B,
    5. Langeron O,
    6. Nicolas-Robin A

    . Benefit of a single recruitment maneuver after an apnea test for the diagnosis of brain death. Crit Care 2012;(16):R116.
25. 25.↵
    1. Mascia L,
    2. Pasero D,
    3. Slutsky AS,
    4. Arguis MJ,
    5. Berardino M,
    6. Grasso S,
    7. et al

    . Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA 2010;304(23):2620–2627.

    OpenUrlCrossRefPubMedWeb of Science